We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correspondence |

Parkinsonism and Cancer

Glen E. Kisby, PhD; Peter S. Spencer, PhD, FRCPath
JAMA Neurol. 2013;70(3):414-415. doi:10.1001/jamaneurol.2013.1283.
Text Size: A A A
Published online


Kareus and colleagues1 propose genetic links to explain an association between Parkinson disease (PD plus other parkinsonian disorders) and certain cancers, specifically melanoma and prostate cancer, across 3 generations in Utah. Closely knit populations, such as those in Utah, might also share etiologically relevant transgenerational exposures; witness Guam parkinsonism-dementia, which associates with foods containing the cycad toxin cycasin, the glucoside of methylazoxymethanol.2 The carcinogenic and neurotoxic properties of methylazoxymethanol are both mediated by DNA damage, changes in microRNA expression, and gene perturbation, the outcome ranging from proliferation for cycling cells (tumorigenesis) to degeneration for postmitotic neurons.3 Pathways in cancer, melanogenesis, and prostate cancer are 3 of the top 9 perturbed cell-signaling pathways in the brains of mice treated systemically with methylazoxymethanol.4 Methylazoxymethanol disrupts the PI3K-AKT-mTOR pathway, which is implicated in both melanogenesis and prostate cancer.5 The methylazoxymethanol metabolite formaldehyde, which is elevated in prostate cancer,6 is a member of the 1-carbon pool, use of which is impacted by the enzyme activity of methylenetetrahydrofolate reductase (MHTFR), and MTHFR polymorphisms are linked to the risk for PD, prostate cancer, and skin cancer, including melanoma.79

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
[Cell therapy for Parkinson's disease]. Nihon Yakurigaku Zasshi 2016;147(5):264-8.

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Make the Diagnosis: Parkinsonism